What if non-invasive testing could help detect non-alcoholic fatty liver disease early on? Liver disease and in particular non-alcoholic fatty liver (NAFLD) disease is one of the emerging public health issues of today. How can non-invasive testing and new pathways screening for liver disease help to tackle the disease early on?